Progenics Pharmaceuticals (PGNX) Stock Analyst Ratings
NASDAQ:PGNX - Nasdaq -
ChartMill assigns a Buy % Consensus number of 100% to PGNX. The Buy consensus is the weighted average rating of the current analysts ratings.
PGNX was analyzed by 1 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about PGNX.
In the previous month the buy percentage consensus was at a similar level.
Only 1 analysts analyzed PGNX. So this is just the average opinion of a couple of analysts.